Trends in health care–associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys

BACKGROUND: Health care–associated infections are a common cause of patient morbidity and mortality. We sought to describe the trends in these infections in acute care hospitals, using data from 3 national point-prevalence surveys. METHODS: The Canadian Nosocomial Infection Surveillance Program (CNISP) conducted descriptive point-prevalence surveys to assess the burden of health care–associated infections on a single day in February of 2002, 2009 and 2017. Surveyed infections included urinary tract infection, pneumonia, Clostridioides difficile infection, infection at surgical sites and bloodstream infections. We compared the prevalence of infection across the survey years and considered the contribution of antimicrobial-resistant organisms as a cause of these infections. RESULTS: We surveyed 28 of 33 (response rate 84.8%) CNISP hospitals (6747 patients) in 2002, 39 of 55 (response rate 71.0%) hospitals (8902 patients) in 2009 and 47 of 66 (response rate 71.2%) hospitals (9929 patients) in 2017. The prevalence of patients with at least 1 health care–associated infection increased from 9.9% in 2002 (95% confidence interval [CI] 8.4%–11.5%) to 11.3% in 2009 (95% CI 9.4%–13.5%), and then declined to 7.9% in 2017 (95% CI 6.8%–9.0%). In 2017, device-associated infections accounted for 35.6% of all health care–associated infections. Methicillin-resistant Staphylococcus aureus (MRSA) accounted for 3.9% of all organisms identified from 2002 to 2017; other antibiotic-resistant organisms were uncommon causes of infection for all survey years. INTERPRETATION: In CNISP hospitals, there was a decline in the prevalence of health care–associated infection in 2017 compared with previous surveys. However, strategies to prevent infections associated with medical devices should be developed. Apart from MRSA, few infections were caused by antibiotic-resistant organisms.

[1]  K. Mertens,et al.  Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis , 2019, The Lancet. Infectious diseases.

[2]  M. Mulvey,et al.  Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010–16 , 2018, The Journal of antimicrobial chemotherapy.

[3]  R. Lynfield,et al.  Changes in Prevalence of Health Care–Associated Infections in U.S. Hospitals , 2018, The New England journal of medicine.

[4]  M. Taljaard,et al.  The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015) , 2018, Canadian Medical Association Journal.

[5]  Herman Goossens,et al.  Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  D. Gravel,et al.  Periprosthetic Infection following Primary Hip and Knee Arthroplasty: The Impact of Limiting the Postoperative Surveillance Period , 2016, Infection Control & Hospital Epidemiology.

[7]  M. Mulvey,et al.  Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014 , 2016, Antimicrobial Agents and Chemotherapy.

[8]  G. Gabutti,et al.  Temporal trends of healthcare associated infections and antimicrobial use in 2011-2013, observed with annual point prevalence surveys in Ferrara University Hospital, Italy , 2016, Journal of preventive medicine and hygiene.

[9]  D. Gravel,et al.  Assessing the magnitude and trends in hospital acquired infections in Canadian hospitals through sequential point prevalence surveys , 2016, Antimicrobial Resistance & Infection Control.

[10]  M. Mulvey,et al.  Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012 , 2016, Infection Control & Hospital Epidemiology.

[11]  P. Malani,et al.  Diagnosis and treatment of Clostridium difficile in adults: a systematic review. , 2015, JAMA.

[12]  S. Berenholtz,et al.  Introduction to “A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals: 2014 Updates” , 2014, Infection Control & Hospital Epidemiology.

[13]  M. Kaouache,et al.  A survey of Preventive Measures Used and their Impact on Central Line-Associated Bloodstream Infections (CLABSI) in Intensive Care Units (SPIN-BACC) , 2013, BMC Infectious Diseases.

[14]  D. Gravel,et al.  A point prevalence survey of health care-associated infections in Canadian pediatric inpatients. , 2012, American journal of infection control.

[15]  M. Olona,et al.  Prevalence of nosocomial infections in acute care hospitals in Catalonia (VINCat Program). , 2012, Enfermedades infecciosas y microbiologia clinica.

[16]  D. Calfee,et al.  Crisis in hospital-acquired, healthcare-associated infections. , 2012, Annual review of medicine.

[17]  J. Dalton,et al.  A unified approach to measuring the effect size between two groups using SAS , 2012 .

[18]  J. Wille,et al.  Prevalence of nosocomial infections in The Netherlands, 2007-2008: results of the first four national studies. , 2010, The Journal of hospital infection.

[19]  M. Loeb,et al.  Methicillin-Resistant Staphylococcus aureus Colonization or Infection in Canada: National Surveillance and Changing Epidemiology, 1995–2007 , 2010, Infection Control & Hospital Epidemiology.

[20]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[21]  L. Valiquette,et al.  Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  P. Aavitsland,et al.  Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. , 2005, The Journal of hospital infection.

[23]  E. Ventureyra,et al.  Radioisotope shuntograms at the Children’s Hospital of Eastern Ontario , 2005, Child's Nervous System.